After strong results in a trial at Royal Melbourne Hospital, MediKane is raising $2.5 million to take to market NutriKane, our food product with solid scientific evidence of its efficacy in gut health.
NutriKane D helps maintain blood glucose levels, the key issue for people living with a number of conditions including diabetes and metabolic syndrome – it also lowers the GI of most foods when consumed with meals.
NutriKane, which is free of the side-effects of pharmaceuticals, has been shown in internal tests to outperform pharmaceuticals in many cases.
As well as taking NutriKane to market, the money we raise will also fund trials to further quantify the value to diabetes directly and provide the most significant evidence of its efficacy.
Please Login or Signup to access the Investor Information